Frozen Shoulder Syndrome Market Overview

The frozen shoulder syndrome market is estimated to reach at a high CAGR during the forecast period 2023-2030. Frozen shoulder is also known as adhesive capsulitis. It is characterized by stiffness and pain in the shoulder joint. Signs and symptoms typically begin gradually, worsen over time, and resolve, usually within one to three years. There are a number of treatment options for frozen shoulder, both surgical and non-surgical. The best treatment for you will depend on the severity of your symptoms and your overall health. 
 

Frozen Shoulder Syndrome Market Dynamics

The frozen shoulder syndrome market is expected to grow significantly in the coming years, driven by the increasing prevalence of frozen shoulder and the high prevalence of diabetes and cardiovascular diseases, which are risk factors for developing frozen shoulder.

 

Frozen shoulder, also known as adhesive capsulitis, is a condition that affects the shoulder joint. It is characterized by pain and stiffness in the shoulder, and can make it difficult to move the arm. Frozen shoulder typically affects people aged 40-60 years, and is more common in women than men.

 

Diabetes and cardiovascular diseases can increase the risk of developing frozen shoulder. This is because these conditions can damage the nerves and blood vessels in the shoulder, leading to inflammation and stiffness.

 

For More Insights Download Sample

 

The high treatment cost of frozen shoulder is a challenge for the market. However, the increasing demand for effective treatments is expected to offset this challenge.

 

Frozen Shoulder Syndrome Market Segmentation Analysis

By Treatment
  • Physical therapy
  • Medication
  • Joint distension
  • Surgery
  • Others
 
By End-user
  • Hospitals
  • Other
  • Homecare

 

By Region

  • North America
  • South America
  • Europe
  • Asia Pacific
  • Middle East and Africa

 

Major Companies Covered

GlaxoSmithKline plc, Contract Pharmacal Corp, Amneal Pharmaceuticals, Inc., Vintage Pharma, Dr. Reddy's Laboratories Ltd, Emcure Pharmaceuticals Ltd, Marksans Pharma, Shanghai Pharmaceutical Group Co. Ltd., China Resources Pharmaceutical GroupCo., Ltd., Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd.

 

About us

DataM Intelligence 4 Market Research is a premier market research and business consulting firm that empowers businesses with accurate, reliable, and real-time market data and insights across a wide range of industries. Established in 2017, we have collaborated with over 750 companies, delivering valuable market intelligence for more than 6000 markets. Our expertise, extensive industry coverage, and robust research methodology have earned us the trust of our clients, making us their go-to partner for market intelligence needs.

 

At DataM Intelligence, we provide comprehensive, insightful, and actionable market intelligence, helping businesses navigate complex market landscapes and make informed decisions. Our dedicated team of analysts and industry experts possess in-depth knowledge and experience in their respective fields, ensuring the highest levels of accuracy and data integrity. Choose DataM Intelligence for all your market research and business consulting needs and experience the difference our commitment to excellence can make for your business.

 

Media Contact

Company Name: DataM Intelligence
Contact Person: Sonal Kumari
Email: info@datamintelligence.com
Phone:+1 877 441 4866
Country: United States
Website: https://www.datamintelligence.com/

Comments (0)
No login
color_lens
gif
Login or register to post your comment